Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05231655 | Ex VIvo DEtermiNed Cancer Therapy(EVIDENT) | recruiting | — | 600 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06728631 | Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL | active not recruiting | Phase 2 | 22 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER |
| 1 |
| Feb 24, 2025 |
| clinicaltrials |
| NCT06836765 | The Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis | not yet recruiting | — | 100 | Yang jiOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06835426 | High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins | recruiting | N/A | 150 | Algemeen Ziekenhuis Maria MiddelaresOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06389201 | Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients | recruiting | N/A | 30 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06831903 | Radiotherapy of Head and Neck Cancer With SIB | recruiting | — | 750 | Wuerzburg University HospitalOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06829147 | A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)(NPC) | recruiting | — | 500 | Sun Yat-sen UniversityOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06733740 | Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma | recruiting | — | 3,000 | Chinese PLA General HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06733766 | Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer | recruiting | — | 300 | Chinese PLA General HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06827639 | In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients(FUTURE) | not yet recruiting | — | 640 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05733910 | Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma(SIBACIRT) | recruiting | N/A | 42 | CNAO National Center of Oncological HadrontherapyOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03979924 | Mouth Opening, Prevention, Education, Nutrition (OPEN)(OPEN) | active not recruiting | N/A | 175 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04001543 | Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer(SIMPA01) | active not recruiting | N/A | 27 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06470217 | Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma(OPTimal) | recruiting | Phase 2 | 116 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06819605 | Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma(NETCAM-RCT) | not yet recruiting | Phase 2 / Phase 3 | 46 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 0 | Feb 11, 2025 | clinicaltrials |
| NCT04567056 | Specific Methylation Profiles in HNSCC | recruiting | — | 300 | Aalborg University HospitalOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06814067 | Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma | not yet recruiting | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06815705 | Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery | not yet recruiting | N/A | 23 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT01973179 | Re-irradiation of Recurrent Head and Neck Cancer(ReKo) | active not recruiting | — | 50 | Technische Universität DresdenOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06803381 | Somesthesia in Cancer Patients: Variability and Influence on Eating Experience(SOMEST'ALIM2) | not yet recruiting | — | 96 | Hospices Civils de LyonOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06809673 | PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial | enrolling by invitation | — | 400 | Ospedale Policlinico San MartinoOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06806683 | Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy(ITHACA) | active not recruiting | — | 915 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT06807034 | Impact of the Oral Microbiota on Relapse in HNSCC Patients(MICR-ORL) | active not recruiting | Phase 4 | 100 | Institut Sainte CatherineOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT03212404 | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | active not recruiting | Phase 1 | 272 | Checkpoint Therapeutics, Inc.INDUSTRY | 9 | Feb 3, 2025 | clinicaltrials |
| NCT06804863 | Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer | not yet recruiting | N/A | 600 | West China HospitalOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06806189 | Lipiodal Injection Technique for Free Flap Sparing Adjuvant RT Planning in HNC | not yet recruiting | Early Phase 1 | 10 | Western University, CanadaOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT03382158 | International PPB/DICER1 Registry | recruiting | — | 3,400 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06549946 | Ixovex-1 Single Agent and Combination Therapy(IXACT) | recruiting | Phase 1 / Phase 2 | 18 | Psivac LtdINDUSTRY | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06800482 | A Study of Online Follow-up in Patients With Papillary Thyroid Cancer | recruiting | N/A | 388 | West China HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06800768 | The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery | recruiting | — | 40 | Ruijin HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05451303 | Detection of Oral and Throat Cancers Using OralViome Cancer Testing System | recruiting | — | 475 | ViomeINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06174428 | Validity of Viome's Oral/throat Cancer Test | recruiting | — | 1,000 | ViomeINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04544969 | Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC | recruiting | — | 50 | Sun Yat-sen UniversityOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT04857164 | Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China | recruiting | Phase 2 | 150 | Yuankai ShiOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06796270 | Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma | recruiting | N/A | 24 | The Second Affiliated Hospital of Hainan Medical UniversityOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06793761 | A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC | not yet recruiting | Phase 2 | 260 | Beijing Tongren HospitalOTHER | 0 | Jan 27, 2025 | clinicaltrials |
| NCT06788223 | Intraoperative Identification of Parathyroid Adenomas Using PTeye™ and FLUOBEAM® LX: a Prospective Cohort Study(PTeye) | active not recruiting | — | 40 | Aristotle University Of ThessalonikiOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06791005 | A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. | recruiting | Phase 3 | 400 | Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06791226 | Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms | recruiting | N/A | 50 | Peking University Third HospitalOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06791941 | Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer | recruiting | — | 18 | Regina Elena Cancer InstituteOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT05587374 | Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)(GEMSTONE) | active not recruiting | Phase 3 | 490 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06645951 | Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma | recruiting | — | 300 | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo SettoreOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06787807 | Proteomic Analysis of Patients Undergoing Bariatric Surgery | not yet recruiting | N/A | 103 | Universidade Federal de PernambucoOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06787911 | Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer | recruiting | Phase 2 | 14 | Yu WangOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06782555 | A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab | recruiting | Phase 1 / Phase 2 | 71 | ImmunoGenesisINDUSTRY | 1 | Jan 21, 2025 | clinicaltrials |
| NCT06087614 | Dose Escalation Using Hypoxia-adjusted Radiotherapy(DE-HyART) | recruiting | Phase 2 | 124 | Rajiv Gandhi Cancer Institute & Research Center, IndiaOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06779747 | Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology | recruiting | — | 5,850 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06781112 | A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma | not yet recruiting | Phase 2 | 35 | Weiwei ZhangOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT03769506 | ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy | active not recruiting | Phase 3 | 135 | Rakuten Medical, Inc.INDUSTRY | 4 | Jan 16, 2025 | clinicaltrials |
| NCT06349889 | Adebrelimab and Chemoradiotherapy in High-risk LANPC | recruiting | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Jan 15, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2025source: clinicaltrials